Experienced leadership for strategic biopharma partnerships
Multi-year alliances · Asset transitions · Best practices
Biopharma partnerships demand confident and efficient cross-functional team leadership bringing together colleagues from every level of an organization. I work within this setting to bring cohesion, focus, and strategic traction.
Whether sustained over the lifetime of a multi-year alliance, concentrated around a specific deal event, or building an organization's internal capability for partnering at portfolio scale, I tailor my support to the needs at hand.
Engagements often draw on more than one of the areas below, and can extend across the full arc of a partnership: from pre-deal diligence and alliance kick-off to wind-down, with internal capability building and training woven in as needs emerge.

service areas
Where Voyageur can help
Alliance Management
Strategic stewardship of multi-year biopharma partnerships, whether engaging from the start, stepping into an existing alliance, or guiding it through change.
capabilities
Orchestrating governance at any tier, from joint steering committees down to functional sub-committees, with discipline and efficiency.
Bringing together teams of functional experts from both sides of a partnership and giving them the structure, cadence, and clarity to work effectively with their counterparts.
Defining the KPIs that connect partnership activity to the strategic objectives of the deal.
Recognizing when shifts in science, market, or strategy mean the partnership needs to be reset, transformed, or closed out, and guiding the work to effect that change.
outcome
A partnership that holds its strategic shape over the years, with functional teams freed to focus on the work they need to do and senior leaders confident in the trajectory of the partnership.
Asset Transitions
Cross-functional team leadership for the months after a deal closes, whether an asset is coming in through in-license or whole-company acquisition or if it is being spun out through divestment or out-licensing.
capabilities
Mapping the operating model, governance, and resourcing required for a confident transition from one company to the other, so that senior leadership has confidence the deal can be executed and everyone gets to business as usual quickly and efficiently.
Running or supporting the central management office that drives transition activity, monitoring functional progress, resolving issues as they emerge, and keeping the work on pace toward handoff.
Structuring and negotiating the TSA that governs how essential activities will be supported during the transition, with buy-side and sell-side interests both represented.
Coordinating teams supporting asset transitions, whether an asset is coming in through in-license or being spun out through out-licensing.
Assisting both companies and research institutions with intellectual property licensing: identifying prospective licensees and negotiating the agreements that commercialize them.
outcome
An asset that arrives promptly where it's meant to go, with the receiving organization equipped to take it forward or the divesting organization cleanly separated, and senior leadership confident the deal delivered what they signed up for.
Partnering Portfolio Best Practices
Advisory to address common alliance management needs, whether working through an immediate alliance challenge or investing in continuous improvement to transform the alliance management function into a strategic asset for the company.
capabilities
Structured surveys, either internal-only or involving two or more partners of an alliance, to surface where perception is aligned and where it isn't, with the analysis to translate findings into targeted intervention.
Designing the dashboards, escalation pathways, and reporting systems that let alliance leaders track the portfolio in real time and brief the C-suite with confidence.
Assessing where the in-house team is strong, where it's stretched, and where training, tools, or new ways of working would raise the organizational maturity for partnering.
Rationalizing resource allocation and planning to confidently grow or down-shift in step with workload demand, bringing programmatic coherence to a company's alliance portfolio.
Identifying the patterns that recur across alliances and re-calibrating the work to address opportunities for improvement at portfolio scale rather than one alliance at a time.
outcome
An organization recognized as a partner of choice that consistently executes with discipline and confidence at scale, with senior leadership able to see across the portfolio and the in-house team eager to support the next deal.